Clinical Trial Update: Capecitabine, Oxaliplatin, and Gefitinib in Treating Patients With Metastatic Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

This is a clinical trial update for a Phase 1/2 study of capecitabine, oxaliplatin, and gefitinib in metastatic colorectal cancer. The trial status is terminate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Gefitinib (Gefitinib)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Colorectal Cancer | Phase 1, Phase 2 | Status: TERMINATED